Pros and Cons of Extended-Release Antiepileptic Drugs
Dr Wilner discusses the problem of medication adherence in epilepsy, and the ways in which extended-release treatments may help address it.
Risk for ICH With Cavernous Malformations
Dr Mark Alberts discusses a recent study exploring the natural history of cavernous malformations and how their different features contribute to intracerebral hemorrhage risk.
New CDC Opioid Guideline: The Good, the Bad, the Ugly
The CDC recently published a guideline for prescribing opioids for chronic pain. Dr Argoff takes a critical look at it from the perspective of a clinician.
Six New Studies Illuminate Causes and Comorbidities in Migraine
Dr Christoph Diener surveys new data on the causes, treatment, and comorbidities of migraine.
It's Ethically Wrong to Diagnose Clinton and Trump From Afar
It may be interesting for doctors to diagnose presidential candidates whom they haven't actually examined, but an ethicist says that doing so is ethically despicable.
Nilotinib Shows Early Safety in Parkinson' Dementia
Dr Alan Jacobs details a small proof-of-concept study, the first to treat persons with advanced Parkinson's with a tyrosine kinase inhibitor.
Ecological Fallout: ALS Linked to Toxins and Pollutants
In this viewpoint, Dr Barclay looks at a study combining survey results and measurements of pollutants in blood samples to determine several risk factors for developing ALS.
Iconoclastic Breast Surgeon Laura Esserman Challenges the Status Quo
From screening to treatment, breast cancer specialist Laura Esserman is on a quest to individualize patient care, and in doing so she is challenging a number of long-standing practices in cancer care.
- Mark J. Alberts, MD
- Charles E. Argoff, MD
- Jeffrey Cummings, MD
- Hans-Christoph Diener, MD, PhD
- Randolph W. Evans, MD
- Mark Freedman, MD
- Sam Gandy, MD, PhD
- Aaron Gilson, MS, MSSW, PhD
- Werner Hacke, MD, PhD
- Robert A. Hauser, MD
- Richard S. Isaacson, MD
- Andres Kanner, MD
- Helmi Lutsep, MD
- Russell K. Portenoy, MD
- Thomas Roth, PhD
- Randall Schapiro, MD, AB
- Stephen D. Silberstein, MD
- Michael J. Thorpy, MD
- Lynn R. Webster, MD
- Andrew N. Wilner, MD
- Howard L. Zwibel, MD
Eric J. Topol, MD
Director, Scripps Translational Science Institute; Chief Academic Officer, Scripps Health; Professor of Genomics, The Scripps Research Institute; Senior Consultant, Division of Cardiovascular Diseases, Scripps Clinic, La Jolla, California; Editor-in-Chief, Medscape